Human Enterovirus D68 infection - the intricate dance of cells, genes, and invading bugs

Hanne Lillerovde Ørstenvik1, Ann-Kristin Tveten1, Yanran Cao1

  • 1Department of Biological Sciences Ålesund, Faculty of Natural Sciences, Norwegian University of Science and Technology (NTNU), Ålesund, Norway.

Insights

Respiratory co-infections with human enterovirus D68 and bacteria impair lung cell defenses. Viral-only infections boost mucin and immune genes, while co-infections reduce sialic acid production, altering host-pathogen interactions.

Area of Science:

  • * Respiratory tract infections
  • * Molecular mechanisms of co-infections

Background:

  • * Respiratory tract infections are common and can be severe.
  • * Co-infections involving multiple pathogens are frequent but poorly understood.
  • * Lung epithelial cells are key in defense and pathogen entry.

Purpose of the Study:

  • * Investigate molecular mechanisms of human enterovirus D68 (HEV-D68) and bacterial co-infections in lung epithelial cells.
  • * Assess cell viability and gene expression changes over 24 hours.
  • * Understand host-pathogen dynamics during respiratory co-infections.

Main Methods:

  • * Cultured human lung epithelial cells.
  • * Infected cells with HEV-D68 alone, bacteria alone, or co-infected.
  • * Assessed cell viability and performed gene expression analysis (mucin, immune markers, sialic acid biosynthesis genes).

Main Results:

  • * Significant cytopathic effects observed in infected cells.
  • * HEV-D68 monoinfection upregulated mucin genes (MUC2, MUC5AC) and immune markers (TNFα, p38).
  • * Co-infections downregulated sialic acid biosynthesis genes (CMAS, GNE, NANS), indicating impaired receptor restoration.

Conclusions:

  • * Co-infections alter lung epithelial cell responses differently than single infections.
  • * Downregulation of sialic acid biosynthesis genes suggests altered host-pathogen interactions.
  • * Findings provide insights into epithelial defense mechanisms and potential therapeutic targets for respiratory co-infections.